Clarithromycin and Electrocardiogram repolarisation abnormality - a phase IV clinical study of FDA data

Summary:

Electrocardiogram repolarisation abnormality is reported only by a few people who take Clarithromycin.

The phase IV clinical study analyzes which people take Clarithromycin and have Electrocardiogram repolarisation abnormality. It is created by eHealthMe based on reports of 38,353 people who have side effects while taking Clarithromycin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 19, 2023

38,353 people reported to have side effects when taking Clarithromycin.
Among them, 3 people (0.01%) have Electrocardiogram repolarisation abnormality.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 39,349 Clarithromycin users for its effectiveness, alternative drugs and more.

What is Electrocardiogram repolarisation abnormality?

Electrocardiogram repolarisation abnormality is found to be associated with 591 drugs and 284 conditions by eHealthMe.

Number of Clarithromycin and Electrocardiogram repolarisation abnormality reports submitted per year:

Could Clarithromycin cause Electrocardiogram repolarisation abnormality?

Gender of people who have Electrocardiogram repolarisation abnormality when taking Clarithromycin *:

female: 33.33 %
male: 66.67 %

Age of people who have Electrocardiogram repolarisation abnormality when taking Clarithromycin *:

Common drugs people take besides Clarithromycin *:

Common side effects people have besides Electrocardiogram repolarisation abnormality *:

Waist Circumference Increased: 1 person, 33.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 33.33%
Fall: 1 person, 33.33%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 33.33%
Eosinophil Count Decreased: 1 person, 33.33%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 33.33%
Electrocardiogram T Wave Inversion: 1 person, 33.33%
Electrocardiogram T Wave Amplitude Decreased: 1 person, 33.33%
Electrocardiogram St Segment Elevation: 1 person, 33.33%
Electrocardiogram St Segment Depression: 1 person, 33.33%

Common conditions people have *:

Nasal Discomfort: 1 person, 33.33%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 1 person, 33.33%
Hiv Infection: 1 person, 33.33%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 33.33%
Diabetes: 1 person, 33.33%
Agitation (state of anxiety or nervous excitement): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and have Electrocardiogram repolarisation abnormality?

Check whether Electrocardiogram repolarisation abnormality is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Electrocardiogram repolarisation abnormality and when was it recovered:

Electrocardiogram repolarisation abnormality in Clarithromycin

Expand to all the drugs that have ingredients of clarithromycin:

Electrocardiogram repolarisation abnormality and drugs with ingredients of clarithromycin

Alternative drugs to, pros and cons of Clarithromycin:

Clarithromycin (39,349 reports)

Common Clarithromycin side effects:

Browse all side effects of Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Electrocardiogram repolarisation abnormality treatments and more:

Electrocardiogram repolarisation abnormality (950 reports)

COVID vaccines that are related to Electrocardiogram repolarisation abnormality:

All the drugs that are associated with Electrocardiogram repolarisation abnormality:

Electrocardiogram repolarisation abnormality (591 drugs)

All the conditions that are associated with Electrocardiogram repolarisation abnormality:

Electrocardiogram repolarisation abnormality (284 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin (the active ingredients of Clarithromycin) and Clarithromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.